Article
Hepatitis C treatment & management.
Journal of medicine and life - 15 Mar 2014
Andronescu D, Diaconu S, Tiuca N, Purcarea R M, Andronescu C I
Abstract excerpt
Combination therapy with pegylated interferon alfa (PEG-IFN alfa) and the nucleoside analogue ribavirin is the current standard of care in patients infected with hepatitis C virus (HCV). Patients with HCV genotype 1 have a much less favorable response to therapy and are treated for 12 months, compared with patients infected with genotypes 2 and 3, in whom a 6-month course of therapy is sufficient. If viremia is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
